Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 1 - 50 out of 3,711

Document Document Title
WO/2020/183442A2
The present disclosure relates to phenylpropanoid saccharide esters, methods for the synthesis of libraries of phenylpropanoid saccharide esters with different degree and place of substitution in the sugar core, and their use as antimicr...  
WO/2020/178798A1
The present disclosure describes acyl halide liquid dispersions and tunable methods of treating cellulosic materials with compositions that provide increased hydrophobicity and/or lipophobicity to such materials without sacrificing the b...  
WO/2020/106870A3
Provided herein are genetically modified yeast cells capable of producing one or more human milk oligosaccharides. The yeast cells include one or more heterologous nucleic acids that encode enzymes of a human milk oligosaccharide biosynt...  
WO/2020/140559A1
Provided is a 5-deoxy-D-ribose derivative (III), when the derivative (III) is used for preparing capecitabine, the stereoselectivity is good and the yield is high. Further provided is a preparation method of the derivative, wherein the p...  
WO/2020/132625A1
Methods for the preparation of oligosaccharide products from polysaccharide starting materials are disclosed. The methods include: hydrolyzing a glucosamine-containing polysaccharide starting material, such as heparin or heparosan, under...  
WO/2020/132096A1
The invention provides methods for preparing antibodies and antibody derivatives with controlled levels of core fucosylation. In one aspect, provided herein is a method of controlling the level of afucosylation of an antibody or antibody...  
WO/2020/106870A2
Provided herein are genetically modified yeast cells capable of producing one or more human milk oligosaccharides. The yeast cells include one or more heterologous nucleic acids that encode enzymes of a human milk oligosaccharide biosynt...  
WO/2020/087499A1
Disclosed is a method for preparing a flame retardant silk, the method comprising the following steps: soaking silk in a tannic acid solution with a pH value of 3-4, and raising the temperature to 80-90℃ for a temperature holding treat...  
WO/2020/083733A1
The present invention relates to the compounds of formula (I), and the N-oxides, stereoiso- mers, tautomers and agriculturally or veterinarily acceptable salts thereof wherein the variablesare defined according to the description, (I) Th...  
WO/2020/082162A1
An adjuvant formulation includes a monophosphoryl Lipid A (MPLA) analogue, a Pam3CSK4 analogue, or a muramyldipeptide (MDP) analogue, or combinations thereof. The adjuvant may be formulated in soluble form or in a nanoparticle, such as p...  
WO/2020/078807A1
The present invention relates to a prodrug compound of the general formula I or II. The prodrug compound of formula I or II is suitable for use in a method for treating a disorder relating to the binding of a galectin, such as galectin-3...  
WO/2020/078808A1
The present invention relates to a compound of the general formula I or II. The compound of formula I or II is suitable for use in a method for treating a disorder relating to the binding of a galectin, such as galectin-3 to a ligand in ...  
WO/2020/064787A1
The present disclosure relates generally to terpene glycosides, such as certain such compounds extracted from Stevia rebaudiana Bertoni, Rubus suavissimus, or Siraitia grosvenorii. The disclosure also provides for the use of such compoun...  
WO/2020/068235A1
A method of treating cellulosic materials with a barrier coating comprising at least two polyol and/or saccharide fatty acid ester, having different HBL values, that provides increased water, oil and grease resistance to such materials w...  
WO/2020/068582A1
An alkyd polymer composition for fast-drying, low VOC applications is provided. The alkyd polymer incorporates a minimum required level of a cyclic ether- and hydroxyl-containing composition formed from a sugar alcohol during the alcohol...  
WO/2020/064788A1
The present disclosure relates generally to terpene glycosides, such as certain such compounds extracted from Stevia rebaudiana Bertoni, Rubus suavissimus, or Siraitia grosvenorii. The disclosure also provides for the use of such compoun...  
WO/2018/213824A3
Therapeutics and methods of treating an angiogenesis related pathology in a mammal comprising administering a therapeutically effective dose of a pharmaceutical composition containing a first therapeutic, wherein the first therapeutic bi...  
WO/2020/058889A1
The present patent application relates to the use of an innovative amino acid derivative of glucosamine having the Formula 1 of the general structure which follows, or of a pharmaceutical composition which contains it as a single active ...  
WO/2020/056124A1
The present invention describes tunable methods of treating cellulosic materials with a barrier coating comprising a prolamine and at least one polyol fatty acid ester that provides increased oil and/or grease resistance to such material...  
WO/2020/032272A1
The present invention provides a production method for sugar fatty acid esters. The production method is characterized in that a weakly basic ion exchanger that has a pKb of 3–7 is used as a catalyst to react a fatty acid ester and a s...  
WO/2020/025693A1
Compositions containing monoester derivatives of the primary alcohol residue of a sugar are generally disclosed herein, as well as their use as sweetness enhancers, bitterness maskers, sourness maskers, or astringency reducers, to improv...  
WO/2020/027882A1
Disclosed herein is a method of producing high purity pentagalloyl glucose (PGG), analogues or derivatives thereof, at least 99.9% pure, by washing with dimethyl ether. PGG may be provided in a kit, including a hydrolyzer for dissolving ...  
WO/2020/015612A1
A fucosylated chondroitin sulfate oligosaccharide having the structure as shown in J, and further disclosed is a method for preparing the fucosylated chondroitin sulfate oligosaccharide: using a chondroitin sulfate A salt as a raw materi...  
WO/2020/014669A1
Thrombin-inhibiting acylated pyrazole-pyridone compounds of formula (II) are disclosed herein, as well as pharmaceutical compositions, including tablets, that contain acylated pyrazole- pyridone compounds. These compounds are useful for ...  
WO/2019/230978A1
The present invention provides a tannic acid based surface-active compounds, a method of producing tannic acid based surface-active compounds and a dispersing composition including the Tannic acid based surface-active compounds. Consider...  
WO/2019/228408A1
Provided herein are potent compounds of Formula (I) and uses thereof for inhibiting the activity of D-amino acid oxidase (DAAO) or treating diseases or disorders associated with DAAO, such as a central nervous system (CNS) disorder, pain...  
WO/2019/227525A1
An application of a chitooligosaccharide-based compound as a biomaterial, especially as a fluorescent molecule carrier. The chitooligosaccharide-based compound has a structure represented by formula (I) with chitooligosaccharide having d...  
WO/2019/230979A1
The present invention provides a method of dispersing asphaltene contained in crude oil and method of dispersing asphaltene contained in asphalt cement. Considering the importance of renewable surfactants for long-term sustainable develo...  
WO/2019/227228A1
The present disclosure relates to analogs of N-acetyl glucosamine fluorinated at 4- and/or 6-position(s) and derivatives of xylose at anomeric position for the treatment of a neurological disease, inflammation, cancer and a central nervo...  
WO/2019/230980A1
The present invention provides a method of dispersing crude oil emulsion containing a tannic acid based surface-active compounds. Considering the importance of renewable surfactants for long-term sustainable development we have developed...  
WO/2019/223485A1
A method for synthesizing sucrose-6-ester. The method comprises: (a) in the presence of a polar aprotic solvent, contacting an organic phosphine compound represented by formula I with sucrose and an organic tin compound; (b) removing wat...  
WO/2019/222424A1
Disclosed are cationic lipids which are compounds of Formula (I'). Cationic lipids provided herein can be useful for delivery and expression of mRNA and encoded protein, e.g., as a component of liposomal delivery vehicle, and accordingly...  
WO/2019/197595A3
The invention relates to compounds of formula (I) and their use in eliciting a pro-Thl7 immune response. Further provided are methods of production of said compounds. (Formula I) wherein m is an integer between 4 and 13; n is an integer ...  
WO/2019/197595A2
The invention relates to novel compounds (I), the use of compounds in eliciting a pro-Th17 immune response and related aspects. Further provided are methods of production of said compounds (I).  
WO/2019/196697A1
A small molecule mannose analog for the manufacture of a recombinant antibody having complex N-linked glycans but reduced core fucosylation. Said mannose analog is typically taken in by host cells (e.g. by means of active transport or pa...  
WO/2019/193214A1
The invention relates to a method for obtaining a mixture of sucrose monotartrate and sucrose ditartrate and to the use of same to inhibit precipitations in wine by dissolving same in the wine after a process of fermentation, clarificati...  
WO/2019/193556A1
The invention relates to a method for extracting oligofucanes from brown algae, to the compositions resulting from said extraction, and to the applications thereof. Said method comprises the following successive steps: (a) depolymerisati...  
WO/2019/179325A1
The present invention relates to the field of carbohydrate chemistry, and discloses a preparation method for a surface capsular polysaccharide structural derivative of Gram-positive bacteria. In the present invention, glucose is used as ...  
WO/2019/169496A1
Provided herein are methods of treating constipation in subjects in need thereof. The method includes administering a therapeutically effective dosage of N-acetylglucosamine. Subjects who may benefit from treatment include those having s...  
WO/2019/154195A1
The present invention relates to a novel therapeutic drug for a neurodegenerative disease and an application thereof. Provided is a novel compound of formula (I). The compound can effectively facilitate the proliferation of neural stem c...  
WO/2019/154306A1
Disclosed in the present invention are saccharide derivatives for immune cell surface modification and use thereof. The saccharide derivatives of the present invention are 9-position or 5-position target substituent modified 9-carbon mon...  
WO/2019/151128A1
A cell labeling agent according to the present invention includes a monosaccharide derivative having a six-membered ring structure metabolized by sialic acid in a sialic acid biosynthesis pathway of a cell. Among groups bonded to carbon ...  
WO/2019/053700A3
Probe embodiments for identifying analytes involved in biofuel or bioenergy production, bioremediation, or nutrient cycling as well as methods of making and use are described herein. In some embodiments, probes identifying cellulose degr...  
WO/2019/145562A1
The present invention relates to anew class of sialyltransferase inhibitors. The class features a carbamate or similar moiety on the amine of a neuraminic acid derivative. Such inhibitors are suitable for use as a medicament, for example...  
WO/2019/128410A1
The present invention relates to the preparation of various xylan esterification products, and an application thereof in a drug for preventing, alleviating and/or treating inflammatory diseases. The application of a xylan esterification ...  
WO/2019/119117A1
There are provided compounds of Formula (A) and pharmaceutically acceptable salts and esters thereof, and pharmaceutical compositions thereof, used for the prevention or treatment in a mammal of joint and bone disorders such as arthritis...  
WO/2019/109300A1
Improved enrichment methods for preparing tannic acid compositions that have superior potency in inhibiting D-amino acid oxidase, and superior purity and safety profiles. The tannic acid compositions (e.g., pharmaceutical compositions, n...  
WO/2019/101489A1
The present invention describes an efficient way to isolate a sialic acid from a fermentation broth. The sialic acid contained in the fermentation broth is produced by bacterial fermentation. The inventive process comprises a step of rem...  
WO/2019/092572A1
The present invention relates to new synthetic molecules with agonist activity of human Toll-like Receptor 4 (TLR4), compositions comprising them and uses thereof for the treatment of diseases in which it is useful to induce or increase ...  
WO/2019/088855A1
The invention relates to branched trehalose glycolipids of Formula (I) and their uses. These compounds are potent Mincle agonists and Th1-stimulating vaccine adjuvants.  

Matches 1 - 50 out of 3,711